AuntMinnie

Representative longitudinal chest CT images and five-year parametric response mapping (PRM), pulmonary vascular CT reconstructions, and hyperpolarized xenon-129 (Xe-129) ventilation MRI scans from survivors of nonsevere and severe COVID-19 pneumonia. (A–F) Images in a 68-year-old male survivor of nonsevere COVID-19 pneumonia, (G–L) 62-year-old male survivor of severe COVID-19 pneumonia, and (M–R) 55-year-old male survivor of severe COVID-19 pneumonia. For each participant, the first three columns show coronal chest CT images from the acute phase (A, G, M), two-year follow-up (B, H, N), and five-year follow-up (C, I, O) (left to right). The fourth column (D, J, P) shows a coronal PRM image for each participant at five-year follow-up derived from paired inspiratory and expiratory CT scans, showing the spatial distribution of lung functional categories. Green indicates normal lung tissue, yellow indicates functional small airway disease, and red indicates emphysema. The second-to-last column shows volume-rendered small pulmonary vessel visualization (red) at five-year follow-up per participant (E, K, Q). The column on the far right (F, L, R) shows a hyperpolarized Xe-129 MRI ventilation defect percentage (VDP) map at five-year follow-up per participant. Dark blue represents high Xe-129 signal intensity, corresponding to well-ventilated lung regions, whereas red represents no Xe-129 signal intensity, corresponding to ventilation defects. At five-year follow-up, the 68-year-old survivor of nonsevere COVID-19 pneumonia (top row) showed near-complete radiologic resolution, no respiratory symptoms, and preserved pulmonary function. In contrast, the 62-year-old survivor of severe COVID-19 pneumonia (middle row) showed persistent fibrotic linear opacities without respiratory symptoms and mildly reduced pulmonary function. The 55-year-old survivor of severe COVID-19 pneumonia (bottom row) showed persistent scattered fibrotic linear opacities and focal emphysematous changes in both lungs, with dyspnea and impaired gas exchange function. The VDP values obtained from F, L, and R were 7.7%, 7.1%, and 6.3%, respectively.

What are the effects of COVID-19 pneumonia after 5 years?

After five years, residual lesions persisted in 35.6% of survivors (37 of 104).

Featured

Nuclear Medicine

USC researchers develop “plug-and-play" platform for PET tracers

Astro

ASTRO 2026 to center on translating radiotherapy data into dialogue

Representative MRI scans for which the independently assigned imaging-derived extranodal extension (iENE) grades differed among the readers. (A) Axial and sagittal images in a 56-year-old male patient with nasopharyngeal carcinoma and cervical nodal metastases. Readers 1 and 3 interpreted the finding as a metastatic lymph node invading the left sternocleidomastoid muscle (arrow) and assessed an iENE grade of 3, whereas reader 2 assigned a grade of 2. After joint review, the radiologists reached a consensus on the absence of definite sternocleidomastoid muscle invasion, and the final iENE grade was 2. (B) Axial and sagittal images in a 52-year-old male patient with nasopharyngeal carcinoma and cervical nodal metastases. Reader 1 interpreted the findings as a single enlarged metastatic lymph node and assessed an iENE grade of 1, whereas readers 2 and 3 interpreted them as two coalescent metastatic lymph nodes (arrows) and assessed a grade of 2. After joint review, the radiologists reached a consensus on the coalescence of the two metastatic lymph nodes, and the final iENE grade was 2.

Image-based grading system estimates nasopharyngeal carcinoma severity

September 23, 2026

Free Webinar: CT Contrast Injection Reimagined

Free Webinar: CT Contrast Injection Reimagined

September 22, 2026

X-rays reveal severe aortic calcification in dialysis patients

September 22, 2026

The Invisible Force Podcast Album Cover

Podcast: OSHA report reveals more about 2023 MRI accident

September 22, 2026

Podcast: MRI safety experts shed light on wishy-washy leadership

More episodes »

Free Webinar: CT Contrast Injection Reimagined

Free Webinar: CT Contrast Injection Reimagined

Check out our Cases of the Week!

48-year-old man with worsening chest pain revisited

A 48-year-old man without significant past medical history with multiple days of worsening chest pain.

40-year-old woman with headaches, focal neurologic deficits revisited

57-year-old woman with chronic shortness of breath revisited

Representative longitudinal chest CT images and five-year parametric response mapping (PRM), pulmonary vascular CT reconstructions, and hyperpolarized xenon-129 (Xe-129) ventilation MRI scans from survivors of nonsevere and severe COVID-19 pneumonia. (A–F) Images in a 68-year-old male survivor of nonsevere COVID-19 pneumonia, (G–L) 62-year-old male survivor of severe COVID-19 pneumonia, and (M–R) 55-year-old male survivor of severe COVID-19 pneumonia. For each participant, the first three columns show coronal chest CT images from the acute phase (A, G, M), two-year follow-up (B, H, N), and five-year follow-up (C, I, O) (left to right). The fourth column (D, J, P) shows a coronal PRM image for each participant at five-year follow-up derived from paired inspiratory and expiratory CT scans, showing the spatial distribution of lung functional categories. Green indicates normal lung tissue, yellow indicates functional small airway disease, and red indicates emphysema. The second-to-last column shows volume-rendered small pulmonary vessel visualization (red) at five-year follow-up per participant (E, K, Q). The column on the far right (F, L, R) shows a hyperpolarized Xe-129 MRI ventilation defect percentage (VDP) map at five-year follow-up per participant. Dark blue represents high Xe-129 signal intensity, corresponding to well-ventilated lung regions, whereas red represents no Xe-129 signal intensity, corresponding to ventilation defects. At five-year follow-up, the 68-year-old survivor of nonsevere COVID-19 pneumonia (top row) showed near-complete radiologic resolution, no respiratory symptoms, and preserved pulmonary function. In contrast, the 62-year-old survivor of severe COVID-19 pneumonia (middle row) showed persistent fibrotic linear opacities without respiratory symptoms and mildly reduced pulmonary function. The 55-year-old survivor of severe COVID-19 pneumonia (bottom row) showed persistent scattered fibrotic linear opacities and focal emphysematous changes in both lungs, with dyspnea and impaired gas exchange function. The VDP values obtained from F, L, and R were 7.7%, 7.1%, and 6.3%, respectively.

What are the effects of COVID-19 pneumonia after 5 years?

Image-based grading system estimates nasopharyngeal carcinoma severity

ASTRO 2026 to center on translating radiotherapy data into dialogue

X-rays reveal severe aortic calcification in dialysis patients

Podcast: OSHA report reveals more about 2023 MRI accident

Multiple Myeloma 400

MRI-based model shows changes over time in multiple myeloma patients

AI cuts chest CT reporting time

Most FDA-cleared AI medical devices not tested on patient outcomes

AI framework could improve MRI quality control in prostate cancer

Longitudinal DBT could help improve long-term cancer risk prediction

Atom Nuclear Lab

ITM touts research studies at ASTRO 2026

UltraSight adds $24 million in new financing

East River Medical Imaging joins Strategic Radiology coalition

ASRT opposes proposal to remove ALARA standard from radiation rules

AdvaHealth gets FDA nod for diagnostic viewer

ASRT files comments on CMS proposed 2027 payment rules

The society shared its perspective on the proposed 2027 OPPS and MPFS rules.

PACS workstations add to power consumption in radiology departments

ASRT opposes proposal to remove ALARA standard from radiation rules

More Practice Management

ASRT files comments on CMS proposed 2027 payment rules

By AuntMinnie.com staff writers

The society shared its perspective on the proposed 2027 OPPS and MPFS rules.

September 24, 2026

ITM touts research studies at ASTRO 2026

By AuntMinnie.com staff writers

Research will be presented on its ITM-11 investigational radiopharmaceutical.

September 24, 2026

Atom Nuclear Lab

UltraSight adds $24 million in new financing

By AuntMinnie.com staff writers

The firm will use the funds in part to expand commercially in the U.S.

September 24, 2026

Money Bills Sky Line

East River Medical Imaging joins Strategic Radiology coalition

By AuntMinnie.com staff writers

The practice offers services for MRI, CT, cardiac imaging, PET/CT, women's imaging, interventional radiology, and more.

September 22, 2026

Radiographer Workstation Smiling 400

ASRT opposes proposal to remove ALARA standard from radiation rules

By AuntMinnie.com staff writers

The U.S. Nuclear Regulatory Commission's proposed rules are anticipated to take effect in early 2027.

September 22, 2026

Nuclear Medicine Worker Sm

AdvaHealth gets FDA nod for diagnostic viewer

By AuntMinnie.com staff writers

The viewer allows radiologists to access images across reading rooms, home offices, and distributed reading locations.

September 22, 2026

Ex-NFL QB Matt Hasselback points brain imaging study

The trial’s main goal it to establish methods for diagnosing chronic traumatic encephalopathy (CTE) in the living, rather that by postmortem exams.

September 21, 2026

Telix inks deal to acquire ITM for $1.65B

By Erik L. Ridley

The deal would create a combined company with significant radioisotope manufacturing, distribution, and radiopharmaceutical development capabilities.

September 21, 2026

Connectivity, wellness, education at center of SDMS annual meeting

By Amerigo Allegretto

Kevin Rooker outlines what attendees can expect at the 2026 SDMS annual meeting in Atlanta.

September 21, 2026

Georgia Atlanta Map Pin (1)

Altis Labs raises $25M for CT AI tool

By AuntMinnie.com staff writers

IPRO is designed to generate survival predictions from routinely acquired CT scans.

September 21, 2026

a2z Radiology secures FDA clearance for CT AI device

By AuntMinnie.com staff writers

The software analyzes abdominopelvic CT images acquired with or without intravenous contrast in adults 22 and older.

September 21, 2026

Better risk scoring could predict cirrhosis, HCC in patients with SLD

By Amerigo Allegretto

One proposed risk score, SAFE, showed modest benefit in patients with imaging-confirmed steatotic liver disease (SLD).

September 21, 2026

Liver Cancer 400